Cardiac telerehabilitation under 5G internet of things monitoring: a randomized pilot study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 11 2023
Historique:
received: 03 07 2023
accepted: 28 10 2023
medline: 6 11 2023
pubmed: 3 11 2023
entrez: 3 11 2023
Statut: epublish

Résumé

Owing to issues such as time and cost, patients often show poor acceptance of and adherence to center-based cardiac rehabilitation (CBCR), which impacts the effectiveness of rehabilitation. Therefore, there is growing interest in home-based cardiac rehabilitation and cardiac telerehabilitation (CTR), which entail less time and cost than CBCR. This study aimed to compare the changes in physiological and psychological indicators, compliance, and satisfaction after CTR and CBCR. In this single-blind, randomized, controlled trial, the intervention group received CTR via the 5G Internet of Things platform, while the control group received CBCR. Data from 50 patients (age 66.28 ± 4.01 years) with acute myocardial infarction who underwent percutaneous coronary intervention were analyzed. After an intervention period of three months, the maximal oxygen uptake and metabolic equivalent of task were 5.53 ± 0.12 and 19.32 ± 0.17, respectively, in the intervention group, and 4.15 ± 0.13 and 16.52 ± 0.18, respectively, in the control group. After three months of intervention, there were significant differences between the two groups in all observed indicators (p < 0.05), except for low-density lipoprotein and the incidence of major adverse cardiovascular events (p > 0.05). The use of a 5G Internet of Things platform cardiac rehabilitation model effectively improved outcomes in patients with acute myocardial infarction who underwent percutaneous coronary intervention. Trials registry: The study protocol was registered at Chinese Clinical Trials Registry (ChiCTR), first trial registration 07/08/2023, identification number ChiCTR2300074435.

Identifiants

pubmed: 37919385
doi: 10.1038/s41598-023-46175-z
pii: 10.1038/s41598-023-46175-z
pmc: PMC10622509
doi:

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18886

Informations de copyright

© 2023. The Author(s).

Références

Environ Health Prev Med. 2020 Sep 5;25(1):48
pubmed: 32891113
Trends Cardiovasc Med. 2017 Aug;27(6):420-425
pubmed: 28318815
Int J Nurs Stud. 2021 Oct;122:104040
pubmed: 34333211
Haematologica. 2020 Jan;105(1):83-90
pubmed: 30975906
Circulation. 2022 Dec 20;146(25):e558-e568
pubmed: 36373541
Curr Psychiatry Rep. 2016 Nov;18(11):101
pubmed: 27671918
Circulation. 2021 Jul 13;144(2):e16-e35
pubmed: 34126755
Heart Lung. 2023 Jan-Feb;57:214-221
pubmed: 36265371
J Telemed Telecare. 2022 Apr 4;:1357633X221085865
pubmed: 35369770
Am J Cardiol. 2022 Jul 15;175:139-144
pubmed: 35570164
Medicine (Baltimore). 2018 Feb;97(8):e9785
pubmed: 29465559
Lancet. 2020 Mar 7;395(10226):785-794
pubmed: 31492501
Mayo Clin Proc. 2017 Feb;92(2):234-242
pubmed: 27855953
Heart. 2016 Aug 1;102(15):1155-6
pubmed: 27067360
J Mol Cell Cardiol. 2022 Mar;164:126-135
pubmed: 34914934
Eur J Prev Cardiol. 2020 Nov;27(16):1747-1755
pubmed: 32321285
J Cardiopulm Rehabil Prev. 2007 Sep-Oct;27(5):303-8; quiz 309-10
pubmed: 17885509
BMJ. 2019 Apr 9;365:l1476
pubmed: 30967483
J Heart Lung Transplant. 2018 Apr;37(4):467-476
pubmed: 28619383
Eur J Phys Rehabil Med. 2023 Apr;59(2):248-258
pubmed: 36692413
Can J Cardiol. 2017 Oct;33(10):1319-1326
pubmed: 28941611
Mayo Clin Proc. 2019 Dec;94(12):2390-2398
pubmed: 31806097
Int J Nurs Stud. 2018 Apr;80:165-180
pubmed: 29471267
Front Psychiatry. 2022 Oct 05;13:983994
pubmed: 36276319
Can J Cardiol. 2023 Jan;39(1):57-62
pubmed: 36604096
Eur J Prev Cardiol. 2019 Jul;26(10):1050-1051
pubmed: 30922103
Int J Cardiol. 2022 Dec 15;369:60-64
pubmed: 35944773
Pharmaceutics. 2023 Mar 22;15(3):
pubmed: 36986889
Curr Med Chem. 2021;28(32):6569-6590
pubmed: 33342402
Psychooncology. 2018 Jun;27(6):1509-1516
pubmed: 29473255
JAMA. 2018 Jun 5;319(21):2223-2224
pubmed: 29872845
Eur J Prev Cardiol. 2017 Aug;24(12):1260-1273
pubmed: 28534417
Prog Cardiovasc Dis. 2022 Jan-Feb;70:40-48
pubmed: 34942234
Front Med (Lausanne). 2022 Aug 03;9:935961
pubmed: 35991646
Circulation. 2017 Jan 24;135(4):398-399
pubmed: 28115415
J Am Coll Cardiol. 2017 Mar 7;69(9):1207-1208
pubmed: 28254186
Br J Anaesth. 2018 Mar;120(3):484-500
pubmed: 29452805
Eur Heart J Qual Care Clin Outcomes. 2022 May 5;8(3):361-367
pubmed: 33895797
Eur J Prev Cardiol. 2018 Jul;25(10):1028-1030
pubmed: 29873239
J Am Coll Cardiol. 2022 Dec 20;80(25):2361-2371
pubmed: 36368511
Medicine (Baltimore). 2020 Mar;99(11):e19556
pubmed: 32176113
Heart Lung. 2022 Sep-Oct;55:117-126
pubmed: 35533492
Eur Heart J Digit Health. 2021 Oct 22;3(1):67-76
pubmed: 36713992
Heart. 2021 Dec;107(24):1935-1937
pubmed: 34667091
EuroIntervention. 2019 Dec 06;15(11):e1014-e1021
pubmed: 31085502

Auteurs

Xiaojie Li (X)

Nursing School, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, Guizhou, China.

Lvheng Zhao (L)

Nursing School, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, Guizhou, China.

Tao Xu (T)

Department of Cardiovascular Internal Medicine, Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.

Guofeng Shi (G)

Nursing School, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, Guizhou, China.

Jie Li (J)

Nursing School, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, Guizhou, China.

Wei Shuai (W)

Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.

Yanqun Yang (Y)

Department of Cardiovascular Internal Medicine, Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.

Yang Yang (Y)

Department of Cardiovascular Internal Medicine, Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.

Weiyi Tian (W)

Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, Guizhou, China. tianweiyi@gzy.edu.cn.

Yixia Zhou (Y)

Nursing School, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, Guizhou, China. zhouyixia2014@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH